28 April 2017
News and Views
Links and Services
Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients, reports April's issue of the American Journal of Gastroenterology.
Anti-tumor necrosis factor (anti-TNF) therapy effects on postoperative complications in Crohn's d
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors